Alpha Teknova (TKNO) and Pluristyx said late Tuesday they are collaborating to produce and commercialize the latter's PluriFreeze product line, a cryopreservative and cell wash media system for allogeneic cell therapies.
Under the partnership, the companies said Teknova will be the exclusive manufacturer and distributor of PluriFreeze in the US and Canada.
The PluriFreeze system, which is entirely synthetic and animal-origin-free, includes a protective wash and a freezing medium designed to support cell therapy development, the companies said.